Yong Yi Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

9/2017	The Antitumor Activity of IMGN529, a CD37-Targeting Antibody-Drug Conjugate, Is Potentiated by Rituximab in Non-Hodgkin Lymphoma Models.
11/2013	A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yong Yi Research Topics

Disease

54	Neoplasms (Cancer) 03/2024 - 11/2010
30	Hepatocellular Carcinoma (Hepatoma) 03/2024 - 07/2012
12	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2010
7	Cholangiocarcinoma 11/2023 - 01/2017
6	Infections 01/2023 - 09/2009
4	Colonic Neoplasms (Colon Cancer) 04/2024 - 01/2023
4	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2022
4	Inflammation (Inflammations) 01/2022 - 09/2015
3	Liver Neoplasms (Liver Cancer) 02/2024 - 02/2016
3	Glioma (Gliomas) 06/2023 - 01/2021
3	Carcinogenesis 01/2022 - 12/2018
2	Hypoxia (Hypoxemia) 02/2024 - 10/2021
2	Leukemia 10/2023 - 01/2017
2	COVID-19 10/2023 - 01/2023
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 06/2021
2	Fibrosis (Cirrhosis) 01/2022 - 06/2018
2	Hepatitis 12/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 03/2017
2	Type 2 Diabetes Mellitus (MODY) 03/2019 - 01/2019
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2017 - 11/2013
1	Cerebral Hemorrhage 05/2024
1	Thrombosis (Thrombus) 12/2023
1	Dehydration (Water Stress) 06/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Syphilis 01/2023
1	Squamous Cell Carcinoma of Head and Neck 01/2023
1	Hematoma 01/2023
1	Disease Progression 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 02/2024 - 03/2002
8	Biomarkers (Surrogate Marker)IBA 03/2023 - 11/2010
7	Messenger RNA (mRNA)IBA 10/2022 - 11/2010
4	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2023
4	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2021 - 03/2017
4	Indicators and Reagents (Reagents)IBA 01/2021 - 10/2016
4	Metformin (Glucophage)FDA LinkGeneric 03/2019 - 01/2017
3	AntibodiesIBA 11/2023 - 01/2018
3	lenvatinibIBA 11/2023 - 01/2022
3	LigandsIBA 01/2023 - 07/2012
3	EnzymesIBA 10/2021 - 06/2012
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2014
3	CateninsIBA 01/2021 - 01/2020
3	Cadherins (E-Cadherin)IBA 01/2020 - 01/2019
2	Twist-Related Protein 1IBA 12/2023 - 06/2020
2	RNA (Ribonucleic Acid)IBA 11/2023 - 03/2013
2	Long Noncoding RNAIBA 06/2023 - 01/2021
2	VaccinesIBA 01/2023 - 09/2009
2	Protein Isoforms (Isoforms)IBA 01/2023 - 01/2021
2	sintilimabIBA 12/2021 - 12/2020
2	MicroRNAs (MicroRNA)IBA 11/2021 - 01/2020
2	CytokinesIBA 11/2021 - 07/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 01/2019
2	Capsules (Microcapsules)IBA 03/2021 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 03/2019 - 03/2017
2	TransferasesIBA 06/2018 - 01/2017
2	AlbuminsIBA 01/2018 - 02/2017
2	C-Reactive ProteinIBA 01/2018 - 03/2017
2	Rituximab (Mabthera)FDA Link 09/2017 - 11/2013
2	naratuximab emtansineIBA 09/2017 - 11/2013
2	Immunoconjugates (Immunoconjugate)IBA 09/2017 - 11/2013
2	AMP-Activated Protein KinasesIBA 03/2017 - 01/2017
2	Vincristine (Oncovin)FDA LinkGeneric 01/2017 - 11/2013
2	Conditioned Culture MediaIBA 04/2013 - 06/2012
2	InterferonsIBA 01/2013 - 11/2012
1	Selenoproteins (Selenoprotein)IBA 02/2024
1	SeleniumIBA 02/2024
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2023
1	Circulating Tumor DNAIBA 12/2023
1	Angiogenesis InhibitorsIBA 11/2023
1	HomoharringtonineIBA 10/2023
1	SaltsIBA 06/2023
1	DiaminesIBA 06/2023
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 06/2023
1	CaprolactamIBA 06/2023
1	ImidesIBA 06/2023
1	pyromellitic dianhydrideIBA 06/2023
1	AmidesIBA 06/2023
1	Sphingosine-1-Phosphate ReceptorsIBA 01/2023
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2023
1	Staphylococcal Protein A (Protein A)IBA 01/2023
1	Chemokine ReceptorsIBA 01/2023
1	Adenosine Triphosphate (ATP)IBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	N2- (1H- indazole- 5- yl)- N6- methyl- 3- nitropyridine- 2,6- diamineIBA 01/2023
1	CalreticulinIBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 01/2023
1	Toll-Like Receptor 3IBA 01/2023

Therapy/Procedure

14	Therapeutics 10/2023 - 01/2017
7	Immunotherapy 03/2024 - 05/2013
6	Hepatectomy 01/2022 - 09/2015
3	Adjuvant Chemotherapy 04/2024 - 01/2023
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2013
2	Mastectomy (Mammectomy) 01/2023 - 01/2022
2	Segmental Mastectomy (Lumpectomy) 01/2023 - 01/2022
1	Renal Dialysis (Hemodialysis) 05/2024
1	Patient Discharge 10/2023
1	Aftercare (After-Treatment) 01/2023
1	Craniotomy 01/2023
1	Radiotherapy 01/2023